Canada Clinical Nutrition Market Size (2024 - 2029)

Canada Clinical Nutrition Market Analysis

The Canada Clinical Nutrition Market size is estimated at USD 1.71 billion in 2024, and is expected to reach USD 2.29 billion by 2029, growing at a CAGR of 6.07% during the forecast period (2024-2029).

The key factors responsible for the market growth include the growing burden of chronic and metabolic diseases, rising cases of diabetes, and the rising geriatric population in the country.

The chronic diseases put a significant burden on Canada's healthcare system. For instance, as per the data published in February 2022 by the Heart and Stroke Foundation Canada, around 750,000 people were living with heart failure, and 100,000 people were diagnosed with this incurable condition each year, which is further expected to increase with the rising aging population and cardiovascular risk factors such as hypertension and smoking, among others. Therefore, there is a growing need for better dietary inclusions in the lives of Canadian people, which is expected to boost the demand for clinical nutrition products in the coming years.

Furthermore, metabolic diseases are one of the key applications of clinical nutrition products. The increasing incidence of diseases such as diabetes in compliance with the rising investment from the Canadian government for diabetes research and development is propelling the growth of the studied market in the country. For instance, as per the Diabetes Canada Report published in February 2022, over 5,719,000 people were suffering from Diabetes in Canada as of 2022, which is expected to reach 7,277,000 by the year 2032. To cope with the rising burden of diabetes, people are inclining more toward dietary changes and adopting clinical nutrition, which is a beneficial factor for the market studied.

Canada's rapidly aging population presents a significant opportunity for the clinical nutrition market. For instance, the Toronto Star newspaper published in February 2023 stated that 1 in 4 Canadians will be older than 65 by 2035. Additionally, seniors account for almost 445 of provincial and territorial healthcare budgets, and unpaid care provision costs Canada an estimated USD 1.3 billion in productivity losses each year. Thus, as the demand for senior care rises, the need for specialized nutritional products and services to address the unique needs of the elderly will continue to grow in the market in the forecast period.

Hence, owing to the above-mentioned factors, such as the growing burden of chronic and metabolic diseases, the growing cases of diabetics, and the rising older population in the country, the market studied is believed to witness significant growth during the forecast period.

However, stringent regulatory policies are expected to hinder market growth in the long run.

Canada Clinical Nutrition Industry Segmentation

As per the scope of this report, clinical malnutrition refers to a condition that can be treated with clinical intervention by using specialized nutrients that are considered proper medications rather than supplements. Clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. Canada's clinical nutrition market is Segmented by route of administration, application, end user, and geography. By route of administration, the market is segmented into oral enteral and parenteral. By application, the market is segmented into nutritional support in malnutrition, nutritional support for metabolic disorders, nutritional support in gastrointestinal diseases, nutritional support in neurological diseases, nutritional support in cancer, and nutritional support in other diseases. By end user, the market is segmented into pediatric and adult. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.